| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. | GENERAL COUNSEL | Restricted Stock Unit (RSU) | 51.6K | $845K | $16.37 | May 15, 2024 | Direct |
| BRISTOL MYERS SQUIBB CO | SVP,ChiefCompliance&EthicsOff. | Common Stock, $0.10 par value | 13.8K | $686K | $49.78 | Jul 30, 2021 | Direct |
| Day One Biopharmaceuticals, Inc. | GENERAL COUNSEL | Restricted Stock Unit (RSU) | 44.3K | $585K | $13.21 | Nov 15, 2024 | Direct |
| Day One Biopharmaceuticals, Inc. | GENERAL COUNSEL | Common Stock | 32.2K | $425K | $13.21 | Nov 18, 2024 | Direct |
| BRISTOL MYERS SQUIBB CO | SVP,ChiefCompliance&EthicsOff. | Common Stock, $0.10 par value | 972 | $48.4K | $49.78 | Jul 30, 2021 | BMS Savings and Investment Program |
| Day One Biopharmaceuticals, Inc. | GENERAL COUNSEL | Stock Option (right to buy Common Stock) | 90K | Jan 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DAWN | Day One Biopharmaceuticals, Inc. | Nov 15, 2024 | 7 | -$41.8K | 4 | Nov 19, 2024 | GENERAL COUNSEL |
| DAWN | Day One Biopharmaceuticals, Inc. | Aug 15, 2024 | 7 | -$44.8K | 4 | Aug 19, 2024 | GENERAL COUNSEL |
| DAWN | Day One Biopharmaceuticals, Inc. | May 15, 2024 | 7 | -$52.3K | 4 | May 17, 2024 | GENERAL COUNSEL |
| DAWN | Day One Biopharmaceuticals, Inc. | Feb 15, 2024 | 7 | -$49.4K | 4 | Feb 20, 2024 | GENERAL COUNSEL |
| DAWN | Day One Biopharmaceuticals, Inc. | Jan 5, 2024 | 2 | $0 | 4 | Jan 9, 2024 | General Counsel |
| DAWN | Day One Biopharmaceuticals, Inc. | Nov 15, 2023 | 5 | -$62.1K | 4 | Nov 17, 2023 | General Counsel |
| DAWN | Day One Biopharmaceuticals, Inc. | Nov 6, 2023 | 0 | $0 | 3 | Nov 16, 2023 | General Counsel |
| BMY | BRISTOL MYERS SQUIBB CO | Jul 30, 2021 | 1 | -$167K | 4 | Aug 3, 2021 | SVP,ChiefCompliance&EthicsOff. |
| BMY | BRISTOL MYERS SQUIBB CO | May 5, 2021 | 1 | -$200K | 4 | May 7, 2021 | SVP,ChiefCompliance&EthicsOff. |